Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | HB0045 |
Synonyms | |
Therapy Description |
HB0045 is a combination of two anti-CD73 monoclonal antibodies, HB0039 and HB0039, which potentially reduces immunosuppression, leading to enhanced antitumor immune response and inhibition of tumor growth (PMID: 39738003). |